-
Cirugia Espanola Mar 2023
Topics: Humans; Appendicitis; Foreign Bodies; Acute Disease
PubMed: 36100048
DOI: 10.1016/j.cireng.2022.09.011 -
PloS One 2018Burden of disease studies intend to improve public health decision-making and to measure social and economic impact in population. The objective of this study was to...
BACKGROUND
Burden of disease studies intend to improve public health decision-making and to measure social and economic impact in population. The objective of this study was to describe the burden of acute respiratory infections (ARI) in Ecuador between 2011 and 2015.
METHODS
Five-year period morbidity and mortality data available from national agencies of statistics was analyzed to estimate the burden of disease attributable to acute respiratory infections. Cases and deaths registered were grouped according to their ICD-10 code into three diagnostic groups: Acute upper respiratory infections (J00-J06), Influenza and pneumonia (J09-J18), and Bronchitis and other acute lower respiratory infections (J20-J22, J85, J86). Disability-adjusted life years stratified by diagnostic and age group were calculated using the "DALY" package for R. The productivity loss in monetary terms was estimated using the human capital method.
RESULTS
Over the 5-year period studied there were a total of 14.84 million cases of acute respiratory infections, with 17 757 deaths reported (0.12%). The yearly burden of disease ranged between 98 944 to 118 651 disability-adjusted life years, with an estimated average loss of productivity of US$152.16 million (±19.6) per year. Approximately 99% of the burden can be attributed to years life lost due to premature mortality in population under 5 years old and over 60 years-old.
CONCLUSIONS
The burden of acute respiratory infections remained steady during the analyzed period. Evidence-based prevention and control policies to tackle acute respiratory infections in Ecuador should focus on the population at extreme ages of life.
Topics: Acute Disease; Adolescent; Adult; Cause of Death; Child; Child, Preschool; Disabled Persons; Ecuador; Efficiency; Female; Humans; Infant; Infant, Newborn; International Classification of Diseases; Male; Middle Aged; Morbidity; Quality-Adjusted Life Years; Respiratory Tract Infections; Young Adult
PubMed: 29715314
DOI: 10.1371/journal.pone.0196650 -
Lancet (London, England) Aug 2015
Topics: Acute Disease; Chronic Disease; Cost of Illness; Disabled Persons; Global Health; Healthy People Programs; Humans; Wounds and Injuries
PubMed: 26333957
DOI: 10.1016/S0140-6736(15)61524-0 -
Aktuelle Urologie Apr 2017
Topics: Acute Disease; Adaptation, Psychological; Anxiety; Caregivers; Chronic Disease; Emotions; Empathy; Humans; Physician's Role; Physician-Patient Relations; Professional-Family Relations; Social Support
PubMed: 28511216
DOI: 10.1055/s-0042-124024 -
Arquivos Brasileiros de Cardiologia Jun 2023
Topics: Humans; Acute Disease; Heart Diseases; Coronary Disease
PubMed: 37341250
DOI: 10.36660/abc.20230283 -
La Revue Du Praticien Dec 2019
Topics: Acute Disease; Humans; Intussusception
PubMed: 32237583
DOI: No ID Found -
Revue de L'infirmiere 2018There are two types of indications of hyperbaric oxygen therapy: it may be used as an emergency treatment in certain acute pathologies or as a therapy for chronic... (Review)
Review
There are two types of indications of hyperbaric oxygen therapy: it may be used as an emergency treatment in certain acute pathologies or as a therapy for chronic long-term pathologies. The indications are regularly updated and assessed through consensus conferences.
Topics: Acute Disease; Chronic Disease; Emergency Medical Services; Humans; Hyperbaric Oxygenation; Oxygen
PubMed: 29907169
DOI: 10.1016/j.revinf.2018.03.012 -
Current Opinion in Neurology Feb 2018Reviewing existing evidence regarding well tolerated and effective antiplatelet treatment in patients with acute or chronic, noncardioembolic ischemic stroke and... (Review)
Review
PURPOSE OF REVIEW
Reviewing existing evidence regarding well tolerated and effective antiplatelet treatment in patients with acute or chronic, noncardioembolic ischemic stroke and transient ischemic attack (TIA).
RECENT FINDINGS
For patients with high-risk stroke or TIA, for instance, minor stroke or high-risk TIA, or stroke of atherosclerotic origin with evidence suggesting risk of artery-to-artery embolism or with high-grade, symptomatic arterial stenosis, early initiated, short-term dual antiplatelet (e.g. aspirin and clopidogrel) is effective in reducing the risk of recurrent stroke and other vascular events which does not increase the risk of severe or fatal bleeding, as compared with mono antiplatelet therapy. However, long-term application of aggressive antiplatelet therapies after a noncardioembolic stroke or TIA increases the bleeding risks. Triple antiplatelet therapy is not appropriate for noncardioembolic stroke or TIA, in view of the high bleeding risk. In addition, emerging antiplatelets such as ticagrelor and cilostazol may work better in certain subgroups of stroke patients, which warrants further investigation.
SUMMARY
Antiplatelet therapies should differ in the acute and chronic phases among patients with high-risk stroke or TIA when more aggressive antiplatelet treatment is reasonable in the acute phase, but no solid evidence supports different antiplatelet strategies in acute and chronic phases in patients with low-risk noncardioembolic stroke.
Topics: Acute Disease; Brain Ischemia; Chronic Disease; Humans; Platelet Aggregation Inhibitors; Stroke
PubMed: 29084062
DOI: 10.1097/WCO.0000000000000509 -
International Journal of Molecular... Aug 2021The current coronavirus disease-19 (COVID-19) pandemic has strongly revived the pressing need to incorporate new therapeutic alternatives to deal with medical situations...
The current coronavirus disease-19 (COVID-19) pandemic has strongly revived the pressing need to incorporate new therapeutic alternatives to deal with medical situations that result in a dramatic breakdown in the body's normal homeostasis [...].
Topics: Acute Disease; COVID-19; Clinical Trials as Topic; Emergency Service, Hospital; Emergency Treatment; Humans; Mesenchymal Stem Cell Transplantation; Regenerative Medicine; Survival Rate; Treatment Outcome
PubMed: 34445102
DOI: 10.3390/ijms22168395 -
Pediatric Nephrology (Berlin, Germany) Mar 2024
Topics: Humans; Child; Acute Disease; Acute Kidney Injury
PubMed: 38114771
DOI: 10.1007/s00467-023-06253-w